TNF Pharmaceuticals Inc.
13F holders, Q3 2025 (September 30)1holders −32
0new positions
31sold out
$0.03avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding TNF Pharmaceuticals Inc. in their 13F filings, down 32 from Q2 2025. 0 opened new positions and 31 sold out. The largest holder was Osaic Holdings, Inc. ($3).
- Company
- TNF Pharmaceuticals Inc.
- CUSIP
- 62856X201
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 31 | $65K |
All 13F filers, Q2 2025 → Q3 2025: 531,546 shares sold, net −531,546 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | No change | 99 | $3 |
"% of holder's portfolio" is TNF PHARMACEUTICALS INC's weight in each manager's 13F, not the share of TNF Pharmaceuticals Inc. the manager owns.